AAIC 2025 Abstract
Regional tau quantification methodologies in early symptomatic participants with presence of tau pathology
By Diana Otero Svaldi, Leonardo Iaccarino, Ixavier Alonzo Higgins, Show 3 more authorsSergey Shcherbinin
Trial in peopleBiomarkers
Abstract
Background: This study compares approaches for defining target regions in their ability to consistently capture tau progression relative to anatomical composites used in Alzheimer's disease trials.
